Progenics, Nektar Still Halted; FDA Advisory Committee Expected To Conclude Thursday
June 12, 2014 at 09:41 AM EDT
Progenics Pharmaceuticals (NASDAQ: PGNX) and Nektar Therapeutics (NASDAQ: NKTR) are halted as investors wait for the FDA panel's ...